These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32415395)

  • 1. The Stabilizing Excipients in Dry State Therapeutic Phage Formulations.
    Zhang Y; Zhang H; Ghosh D
    AAPS PharmSciTech; 2020 May; 21(4):133. PubMed ID: 32415395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manufacturing Stable Bacteriophage Powders by Including Buffer System in Formulations and Using Thin Film Freeze-drying Technology.
    Zhang Y; Soto M; Ghosh D; Williams RO
    Pharm Res; 2021 Oct; 38(10):1793-1804. PubMed ID: 34697726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophage Encapsulation Using Spray Drying for Phage Therapy.
    Malik DJ
    Curr Issues Mol Biol; 2021; 40():303-316. PubMed ID: 32678066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics.
    Rayaprolu BM; Strawser JJ; Anyarambhatla G
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1565-1571. PubMed ID: 29863908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dry powder pharmaceutical biologics for inhalation therapy.
    Chang RYK; Chow MYT; Khanal D; Chen D; Chan HK
    Adv Drug Deliv Rev; 2021 May; 172():64-79. PubMed ID: 33705876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From single excipients to dual excipient platforms in dry powder inhaler products.
    Shur J; Price R; Lewis D; Young PM; Woollam G; Singh D; Edge S
    Int J Pharm; 2016 Dec; 514(2):374-383. PubMed ID: 27262269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational Characterization of Antibody-Excipient Interactions for Rational Excipient Selection Using the Site Identification by Ligand Competitive Saturation-Biologics Approach.
    Jo S; Xu A; Curtis JE; Somani S; MacKerell AD
    Mol Pharm; 2020 Nov; 17(11):4323-4333. PubMed ID: 32965126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H; Wiechert F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive Scientific Survey of Excipients Used in Currently Marketed, Therapeutic Biological Drug Products.
    Rao VA; Kim JJ; Patel DS; Rains K; Estoll CR
    Pharm Res; 2020 Sep; 37(10):200. PubMed ID: 32968854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of novel excipients for freeze-dried protein formulations.
    Holm TP; Meng-Lund H; Rantanen J; Jorgensen L; Grohganz H
    Eur J Pharm Biopharm; 2021 Mar; 160():55-64. PubMed ID: 33508435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excipient Stability in Oral Solid Dosage Forms: A Review.
    Darji MA; Lalge RM; Marathe SP; Mulay TD; Fatima T; Alshammari A; Lee HK; Repka MA; Narasimha Murthy S
    AAPS PharmSciTech; 2018 Jan; 19(1):12-26. PubMed ID: 28895106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brij-58, a potential injectable protein-stabilizer used in therapeutic protein formulation.
    Yue L; Yan Z; Li H; Liu X; Sun P
    Eur J Pharm Biopharm; 2020 Jan; 146():73-83. PubMed ID: 31811896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of storage temperature on the stability of spray dried bacteriophage powders.
    Leung SSY; Parumasivam T; Nguyen A; Gengenbach T; Carter EA; Carrigy NB; Wang H; Vehring R; Finlay WH; Morales S; Britton WJ; Kutter E; Chan HK
    Eur J Pharm Biopharm; 2018 Jun; 127():213-222. PubMed ID: 29486303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Storage stability of inhalable phage powders containing lactose at ambient conditions.
    Chang RYK; Wallin M; Kutter E; Morales S; Britton W; Li J; Chan HK
    Int J Pharm; 2019 Apr; 560():11-18. PubMed ID: 30710661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of formulation and processing factors on stability of levothyroxine sodium pentahydrate.
    Collier JW; Shah RB; Gupta A; Sayeed V; Habib MJ; Khan MA
    AAPS PharmSciTech; 2010 Jun; 11(2):818-25. PubMed ID: 20454876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections.
    Vandenheuvel D; Singh A; Vandersteegen K; Klumpp J; Lavigne R; Van den Mooter G
    Eur J Pharm Biopharm; 2013 Aug; 84(3):578-82. PubMed ID: 23353012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Porous Excipients on the Manufacturability and Product Performance of Solid Self-Emulsifying Drug Delivery Systems.
    Beringhs AO; Minatovicz BC; Zhang GGZ; Chaudhuri B; Lu X
    AAPS PharmSciTech; 2018 Oct; 19(7):3298-3310. PubMed ID: 30218264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of excipients is a poor predictor for aggregation kinetics of biopharmaceutical proteins.
    Zalar M; Svilenov HL; Golovanov AP
    Eur J Pharm Biopharm; 2020 Jun; 151():127-136. PubMed ID: 32283214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Metallic Stearates on Disproportionation of Hydrochloride Salts of Weak Bases in Solid-State Formulations.
    Nie H; Xu W; Ren J; Taylor LS; Marsac PJ; John CT; Byrn SR
    Mol Pharm; 2016 Oct; 13(10):3541-3552. PubMed ID: 27542728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a Biologic Formulation Using Customized Design of Experiment and Novel Multidimensional Robustness Diagrams.
    Maroju RK; Barash S; Brisbane CE
    J Pharm Sci; 2018 Mar; 107(3):797-806. PubMed ID: 29107045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.